Upon inhibition of Aβ plaque clearance from ineffective TREM2 activity, subsequent amyloid accumulations in the brain would lead to sustained neuroinflammatory responses and neuronal death, thereby contributing to memory and cognitive decline, leading to AD onset [11]. Here, TREM2 is linked to Alzheimer disease.